Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.

Gately CM, Podbielska M, Counihan T, Hennessy M, Leahy T, Moran AP, Hogan EL, O'Keeffe J.

J Neuroimmunol. 2013 Jun 15;259(1-2):1-7. doi: 10.1016/j.jneuroim.2013.02.020. Epub 2013 Mar 26.

PMID:
23537888
[PubMed - indexed for MEDLINE]
2.

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Tohn R, Blumenfeld H, Haeryfar SM, Veerapen N, Besra GS, Porcelli SA, Delovitch TL.

Clin Exp Immunol. 2011 Apr;164(1):26-41. doi: 10.1111/j.1365-2249.2011.04323.x. Epub 2011 Mar 1.

PMID:
21361909
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy.

O'Konek JJ, Kato S, Takao S, Izhak L, Xia Z, Illarionov P, Besra GS, Terabe M, Berzofsky JA.

Clin Cancer Res. 2013 Aug 15;19(16):4404-11. doi: 10.1158/1078-0432.CCR-12-2169. Epub 2013 Jun 26.

PMID:
23804426
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.

Dasgupta S, Levery SB, Hogan EL.

J Lipid Res. 2002 May;43(5):751-61.

PMID:
11971946
[PubMed - indexed for MEDLINE]
Free Article
5.

Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.

Podbielska M, Dasgupta S, Levery SB, Tourtellotte WW, Annuk H, Moran AP, Hogan EL.

J Lipid Res. 2010 Jun;51(6):1394-406. doi: 10.1194/jlr.M001396. Epub 2010 Feb 12.

PMID:
20154333
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity.

Wu J, Shin J, Xie D, Wang H, Gao J, Zhong XP.

J Immunol. 2014 Mar 15;192(6):2643-50. doi: 10.4049/jimmunol.1302076. Epub 2014 Feb 14.

PMID:
24532578
[PubMed - indexed for MEDLINE]
7.

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV.

J Immunol. 2009 Mar 1;182(5):2816-26. doi: 10.4049/jimmunol.0803648.

PMID:
19234176
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Croudace JE, Curbishley SM, Mura M, Willcox CR, Illarionov PA, Besra GS, Adams DH, Lammas DA.

BMC Immunol. 2008 Dec 3;9:71. doi: 10.1186/1471-2172-9-71.

PMID:
19055753
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.

Sullivan BA, Kronenberg M.

J Clin Invest. 2005 Sep;115(9):2328-9.

PMID:
16138189
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.

Wu TN, Lin KH, Chang YJ, Huang JR, Cheng JY, Yu AL, Wong CH.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17275-80. doi: 10.1073/pnas.1114255108. Epub 2011 Oct 10.

PMID:
21987790
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.

Wu L, Gabriel CL, Parekh VV, Van Kaer L.

Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Epub 2009 Apr 8. Review.

PMID:
19392798
[PubMed - indexed for MEDLINE]
12.

Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.

Hogan AE, O'Reilly V, Dunne MR, Dere RT, Zeng SG, O'Brien C, Amu S, Fallon PG, Exley MA, O'Farrelly C, Zhu X, Doherty DG.

Clin Immunol. 2011 Aug;140(2):196-207. doi: 10.1016/j.clim.2011.03.016. Epub 2011 Apr 13.

PMID:
21493160
[PubMed - indexed for MEDLINE]
13.

Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.

Aspeslagh S, Li Y, Yu ED, Pauwels N, Trappeniers M, Girardi E, Decruy T, Van Beneden K, Venken K, Drennan M, Leybaert L, Wang J, Franck RW, Van Calenbergh S, Zajonc DM, Elewaut D.

EMBO J. 2011 Jun 1;30(11):2294-305. doi: 10.1038/emboj.2011.145. Epub 2011 May 6.

PMID:
21552205
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.

Emoto M, Shimizu T, Koike H, Yoshizawa I, Hurwitz R, Kaufmann SH, Emoto Y.

Immunology. 2010 Jan;129(1):62-74. doi: 10.1111/j.1365-2567.2009.03148.x.

PMID:
20028429
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.

Iyoda T, Ushida M, Kimura Y, Minamino K, Hayuka A, Yokohata S, Ehara H, Inaba K.

Int Immunol. 2010 Nov;22(11):905-13. doi: 10.1093/intimm/dxq444.

PMID:
21118907
[PubMed - indexed for MEDLINE]
Free Article
16.

Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts.

Bennion B, Dasgupta S, Hogan EL, Levery SB.

J Mass Spectrom. 2007 May;42(5):598-620.

PMID:
17370250
[PubMed - indexed for MEDLINE]
17.

Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.

Fujita H, Teng A, Nozawa R, Takamoto-Matsui Y, Katagiri-Matsumura H, Ikezawa Z, Ishii Y.

J Immunol. 2009 Jul 1;183(1):254-60. doi: 10.4049/jimmunol.0800520.

PMID:
19542437
[PubMed - indexed for MEDLINE]
Free Article
18.

Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N.

Immunology. 2010 Jun;130(2):296-306. doi: 10.1111/j.1365-2567.2009.03235.x. Epub 2010 Jan 27.

PMID:
20113367
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

O'Keeffe J, Gately CM, Counihan T, Hennessy M, Leahy T, Moran AP, Hogan EL.

J Neurol Sci. 2008 Dec 15;275(1-2):22-8. doi: 10.1016/j.jns.2008.07.007. Epub 2008 Aug 15.

PMID:
18706662
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients.

Boucher A, Desforges M, Duquette P, Talbot PJ.

Clin Immunol. 2007 Jun;123(3):258-67. Epub 2007 Apr 19.

PMID:
17448727
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk